| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. | Schizophr Res | 2003 | 1.86 |
| 2 | Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. | J Psychopharmacol | 2006 | 1.20 |
| 3 | Changes in bone mineral density after 96 weeks of treatment with atazanavir/ritonavir or lopinavir/ritonavir plus tenofovir DF/emtricitabine in treatment-naive patients with HIV-1 infection: the CASTLE body composition substudy. | J Acquir Immune Defic Syndr | 2015 | 0.84 |